Pacific Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PACB and other ETFs, options, and stocks.

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. 

CEO
Christian O. Henry
CEOChristian O. Henry
Employees
575
Employees575
Headquarters
Menlo Park, California
HeadquartersMenlo Park, California
Founded
2000
Founded2000
Employees
575
Employees575

PACB Key Statistics

Market cap
756.64M
Market cap756.64M
Price-Earnings ratio
-1.08
Price-Earnings ratio-1.08
Dividend yield
Dividend yield
Average volume
8.89M
Average volume8.89M
High today
$2.37
High today$2.37
Low today
$2.11
Low today$2.11
Open price
$2.12
Open price$2.12
Volume
11.63M
Volume11.63M
52 Week high
$2.73
52 Week high$2.73
52 Week low
$0.8511
52 Week low$0.8511

Stock Snapshot

With a market cap of 756.64M, Pacific Biosciences(PACB) trades at $2.34. The stock has a price-to-earnings ratio of -1.08.

As of 2026-01-14, Pacific Biosciences(PACB) stock has fluctuated between $2.11 and $2.37. The current price stands at $2.34, placing the stock +10.8% above today's low and -1.3% off the high.

The Pacific Biosciences(PACB)'s current trading volume is 11.63M, compared to an average daily volume of 8.89M.

In the last year, Pacific Biosciences(PACB) shares hit a 52-week high of $2.73 and a 52-week low of $0.85.

In the last year, Pacific Biosciences(PACB) shares hit a 52-week high of $2.73 and a 52-week low of $0.85.

PACB News

TipRanks 2d
PacBio announces plans for n-Lorem Foundation collaboration

PacBio (PACB) announced plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare that we believe will position long-read whole-genome...

TipRanks 6d
PacBio, UC Davis Researchers introduce CiFi

PacBio (PACB) announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome assemblies from a single sequencing run....

Simply Wall St 7d
Pacific Biosciences Is Up 13.9% After Revio, Vega and SPRQ-Nx Drive New Customer Growth

In its most recent quarter, Pacific Biosciences of California reported strong uptake of its Revio and Vega sequencing platforms and launched the SPRQ-Nx chemist...

Pacific Biosciences Is Up 13.9% After Revio, Vega and SPRQ-Nx Drive New Customer Growth

Analyst ratings

60%

of 10 ratings
Buy
40%
Hold
60%
Sell
0%

People also own

Based on the portfolios of people who own PACB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .